Entering text into the input field will update the search result below

Rocket Pharmaceuticals to reveal first AAV gene therapy program on November 26

  • Rocket Pharmaceuticals (NASDAQ:RCKT) will host a conference call on November 26th, at 8:30 a.m. ET to reveal their first adeno-associated viral vector (AAV) gene therapy program.

Recommended For You

More Trending News

About RCKT Stock

SymbolLast Price% Chg
Market Cap
PE
Yield (TTM)
Rev Growth (YoY)
Prev. Close
Compare to Peers

Related Stocks

SymbolLast Price% Chg
RCKT--
Rocket Pharmaceuticals, Inc.